| 000 | 01109 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516133544.0 | ||
| 264 | 0 | _c20130930 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1532-2777 | ||
| 024 | 7 |
_a10.1016/j.mehy.2013.01.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFarjam, Mojtaba | |
| 245 | 0 | 0 |
_aCD21 positive B cell: a novel target for treatment of multiple sclerosis. _h[electronic resource] |
| 260 |
_bMedical hypotheses _cMay 2013 |
||
| 300 |
_a556-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aEpstein-Barr Virus Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Immunological |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Complement 3d _xantagonists & inhibitors |
| 700 | 1 | _aEbrahimpour, Azin | |
| 700 | 1 | _aFakhraei, Bahareh | |
| 773 | 0 |
_tMedical hypotheses _gvol. 80 _gno. 5 _gp. 556-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mehy.2013.01.016 _zAvailable from publisher's website |
| 999 |
_c22480710 _d22480710 |
||